alexa James L. Sherley | The Adult Stem Cell Technology Cente
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

James L. Sherley

James L. Sherley, M.D., Ph.D.
Director
The Adult Stem Cell Technology Center
LLC P.O. Box 301179 Boston
Massachusetts 02130, USA
Tel. 617-990-6819
E-Mail: [email protected]
Biography

Dr. James L. Sherley graduated from Harvard College with a B.A. in biology in 1980 and completed joint M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine in 1988. Thereafter, at Princeton University as a post-doctoral fellow, he investigated cellular mechanisms of p53 gene growth regulation. In 1991, as a new principal investigator, Dr. Sherley continued his studies of p53 that led to his future seminal research to elucidate molecular mechanisms involved in asymmetric self-renewal by tissue stem cells. In 1998, he moved to the Massachusetts Institute of Technology where he began research to translate his discovery of p53-dependent asymmetric self-renewal into bioengineered solutions for longstanding barriers to progress in adult stem cell-based biomedicine. In 2007, Dr. Sherley joined the faculty of the Boston Biomedical Research Institute (BBRI) as a Senior Scientist to continue development of novel biotechnologies for quantifying and producing human tissue stem cells. At BBRI, he founded the Adult Stem Cell Technology Center (ASCTC); and later, after BBRI’s closure in 2013, he established this research center as a limited liability company, which he now directs. The ASCTC, LLC deploys its unique portfolio of tissue stem cell biotechnology patents to engineer processes for mass-producing human tissue stem cells for applications in drug development and transplantation medicine. Dr. Sherley has published 64 original scientific research articles, book chapters, lectures, perspectives, and reviews, as well as 34 articles in the public service of science and society education. In recognition of his research accomplishments, he received the Pew Charitable Trusts’ Scholar Award in Biomedical Science, the Ellison Medical Foundation Senior Scholar Award in Aging Research, and the National Institutes of Health Director’s Pioneer Award.

Research Interest

Elucidate molecular mechanisms involved in asymmetric self-renewal by tissue stem cells

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords